Cargando…

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study

BACKGROUND: Clusterin, a glycoprotein implicated in Alzheimer’s disease (AD), remains unclear. The objective of this study was to analyze the effect of cerebrospinal fluid (CSF) clusterin in relation to AD biomarkers using a longitudinal cohort of non-demented individuals. METHODS: We gathered a sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao, Ma, Ling-Zhi, Sheng, Ze-Hu, Liu, Jia-Yao, Yuan, Wei-Yu, Guo, Fan, Zhang, Wei, Tan, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629112/ https://www.ncbi.nlm.nih.gov/pubmed/37941999 http://dx.doi.org/10.3389/fnagi.2023.1256389

Ejemplares similares

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023)

Cerebrospinal fluid neurofilament dynamic profiles predict cognitive progression in individuals with de novo Parkinson’s disease
por: Sheng, Ze-Hu, et al.
Publicado: (2022)

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer’s disease
por: Wan, Mei-dan, et al.
Publicado: (2022)

Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer’s Disease Patients
por: Ju, Ting, et al.
Publicado: (2022)

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer’s Disease and Mild Cognitive Impairment
por: Dong, Ningxin, et al.
Publicado: (2022)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

Different Profiles of Spatial Navigation Deficits In Alzheimer’s Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2022)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Age-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease
por: Chua, Jacqueline, et al.
Publicado: (2022)

Altered Prefrontal Blood Flow Related With Mild Cognitive Impairment in Parkinson's Disease: A Longitudinal Study
por: Wang, Jian, et al.
Publicado: (2022)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
por: Wang, Jun, et al.
Publicado: (2020)

Identification and validation of biomarkers based on cellular senescence in mild cognitive impairment
por: Ma, Songmei, et al.
Publicado: (2023)

Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults
por: Eldridge, Ronald C., et al.
Publicado: (2022)

A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2022)

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease: A Proof-of-Concept Six Years Prospective Study
por: Ferreri, Florinda, et al.
Publicado: (2021)

Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics
por: Long, Zhuqing, et al.
Publicado: (2023)

Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
por: Lu, Yuanyuan
Publicado: (2022)

Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer’s pathology
por: Hu, Hao, et al.
Publicado: (2020)

Corrigendum: A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2023)

Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022)

Enhancement of Visuospatial Working Memory by the Differential Outcomes Procedure in Mild Cognitive Impairment and Alzheimer’s Disease
por: Vivas, Ana B., et al.
Publicado: (2018)

Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer’s disease defined by fluorodeoxyglucose-positron emission tomography
por: Kato, Takashi, et al.
Publicado: (2022)

Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
por: Yang, Xin-Yu, et al.
Publicado: (2021)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Mitigating effects and mechanisms of Tai Chi on mild cognitive impairment in the elderly
por: Wang, Xin, et al.
Publicado: (2023)

Specific White Matter Tracts and Diffusion Properties Predict Conversion From Mild Cognitive Impairment to Alzheimer’s Disease
por: Stone, David B., et al.
Publicado: (2021)

Identification of Genetic Networks Reveals Complex Associations and Risk Trajectory Linking Mild Cognitive Impairment to Alzheimer’s Disease
por: Strafella, Claudia, et al.
Publicado: (2022)

Eliciting Implicit Awareness in Alzheimer’s Disease and Mild Cognitive Impairment: A Task-Based Functional MRI Study
por: Tondelli, Manuela, et al.
Publicado: (2022)

Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Chen, Yanru, et al.
Publicado: (2022)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

Vision transformers for the prediction of mild cognitive impairment to Alzheimer’s disease progression using mid-sagittal sMRI
por: Hoang, Gia Minh, et al.
Publicado: (2023)

Effects of Sport Stacking on Neuropsychological, Neurobiological, and Brain Function Performances in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Controlled Trial
por: Yang, Ziying, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Yeh, Tsai-Chu, et al.
Publicado: (2022)

Blood levels of circulating methionine components in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
por: Zhao, Yan, et al.
Publicado: (2022)

Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease
por: Mi, Yan, et al.
Publicado: (2023)

A Comparative Study of Structural and Metabolic Brain Networks in Patients With Mild Cognitive Impairment
por: Wei, Cuibai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m6ch6tat4e8pkvh4fcguab7k3i